Standard & Poor’s assigned  ‘BBB+’ and ‘BB+’ ratings to the class A and B notes to be issued by Aetna’s $150 million Vitality Re IV Ltd. (Series 2013-1), a health insurance-linked securitization.

This is the fourth in Aetna’s series of Vitality Re deals and it provides the insurer with additional reinsurance against a rise in medical benefit claims rates. BNP Paribas is lead manager on the deal, according to the S&P presale report.

Subscribe Now

Access to a full range of industry content, analysis and expert commentary.

30-Day Free Trial

No credit card required. Access coverage of the securitization marketplace, including breaking news updated throughout the day.